CCR asco

2. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

3. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

4. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

5. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

6. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

7. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

8. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

9. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

10. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

11. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

12. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

13. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

14. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

15. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

16. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

17. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

18. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

19. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

20. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

21. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

22. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

23. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

24. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

25. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

26. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

27. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

28. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

29. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

30. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

31. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

32. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

33. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

34. Abstract #3611 CALGB80405 - QoL
»Phase III trial
»Primary endpoint: OS
»Secondary endpoints: ORR, PFS, TTF, DOR, safety
Untreated
KRAS WT
mCRC
(n=1,500)
Bevacizumab
+ FOLFOX
or FOLFIRI
Cetuximab
+ FOLFOX
or FOLFIRI
PD
PD
R

35. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

36. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

37. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

38. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

39. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

40. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

41. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

42. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

43. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

44. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

45. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting

46. [TITLE]
Presented By Richard H. Wilson, MD at 2013 ASCO Annual Meeting